We found that our NK-AML subgroup was split into two distinctive clusters based on DNA methylation, and that mutations in WT1, FLT3, and CEBPA were overrepresented in one of the clusters (Cluster B), while the other cluster contained few mutations (Cluster A). The gene discussed is WT1; the disease is acute myeloid leukemia.